All reagents were purchased from Sigma-Aldrich or Macrocyclics and used without further purification. RP-HPLC analyses were performed on a Jupiter 4µ Proteo 90Å Phenomenex column (150 x 4.60 mm) with a binary gradient at a flow rate of 1 mL/min using a HitachiElite LaChrom L-2130 pump equipped with UV-Vis detector (Hitachi-Elite LaChrom L-2420). For purification, a semi-preparative Phenomenex Jupiter 4µ Proteo 90Å column (250 x 10.0mm) was utilized at a flow rate of 4 mL/min. For both analytical and semi-preparative RP-HPLC, the following mobile phases were used: Eluant A = 0.1% TFA in water; Eluant B = 99.9% acetonitrile, 0.1% TFA.
1 H (300 and 400 MHz) and 13 C (100 MHz) NMR spectra were recorded on a Varian Mercury Plus spectrometer. Mass spectra were obtained at the and 99 ms and 6 repetition times of 5000, 3000, 2500, 2000, 1500, and 1200 ms, and a flip angle of 180º.
Analysis of T 1 Data
To correct for minor scan-to-scan variations due to noise, T 1 was normalized to pre-injection phantom relaxivities. Phantoms of Gd-DOTA, SMN or FMN, were included in each scan corresponding to the material injected. Concentrations selected were 0.41, 0.12, 0.033, 0.0095, and 0.0027 mM with respect to Gd 3+ in H 2 O. Pre-injection relaxivities were generated for each mouse by averaging 1/T 1 (r 1 ) values (sec -1 ) for each phantom concentration over 4 selected slices of the mouse (The selected slices were those in which the organs of interest were visible). For each scanning time point after injection, an average 1/T 1 for 5 phantoms were calculated and compared to the pre-injection relaxivity value to generate an adjustment factor for the scan of interest. Relaxivity values generated from phantoms for each scan were within (+/-) 1 -20% of the pre-injection phantom relaxivity. After organ ROI T 1 was converted to 1/T 1 , each were multiplied by the adjustment factor. 1/T 1 was averaged over each organ and then converted back to T 1 (msec). Normalized T 1 were averaged over three mice for each time point sampled and each material. Error for urinary bladder and liver are standard errors, over three mice for each material, using normalized T 1 for each specific time point sampled. 
a) STEM-HAADF of SMN with area chosen for EDS analysis (annotated as spectrum 2).

b) EDS of SMN from the area selected in (a). Iron and copper signals are artifacts from the specimen holder and copper grid.
8 Figure S6 . STEM-EDS Analysis of FMN.
a) STEM-HAADF of FMN with area chosen for EDS analysis (annotated as spectrum 1).
b) EDS of FMN from the area selected. Iron and copper signals are artifacts from the specimen holder and copper grid.
9 Figure S7 . FMN phase analysis. Three TEM images were analyzed for %volume fibrillar phase (scale bar = 250nm). Lengths of fibrillar particles were measured in ImageJ, as indicated by the yellow lines above in representative TEM images (1)- (3), above. Diameter of the fibers was assumed to be the same as the spheres, and volume was calculated using the average sphere radius. Volume of the spheres was calculated accordingly, and summation of volume of tabulated spheres and fibers was used to determine respective ratios, as listed in Table S1 . Table S1 . Measured volumes of spheres and non-spheres in FMN.
10 Figure S8 . TEM of SMN, imaged 14 months after preparation. 
a) and b) TEM of SMN¸negative staining using 1% uranyl acetate c)-f) TEM of SMN¸no staining
